Aug 5, 2026 10:26AM

Aug 5, 2026 10:25AM

Jul 16, 2026 10:00AM

Jul 16, 2026 06:45AM

Jul 16, 2026 06:45AM

Jul 6, 2026 06:00AM

Jul 6, 2026 06:00AM AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

Jun 25, 2026 06:00AM

May 12, 2026 08:00AM

Apr 20, 2026 06:43AM

Apr 20, 2026 06:08AM

Apr 8, 2026 06:00AM

Apr 8, 2026 06:00AM

Mar 18, 2026 07:58AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Mar 17, 2026 06:00AM

Mar 17, 2026 06:00AM

Mar 10, 2026 06:00AM

Mar 10, 2026 06:00AM

Mar 6, 2026 03:37PM

Mar 6, 2026 07:00AM

Mar 3, 2026 07:00AM AtaiBeckley receives FDA support for BPL-003 Phase 3 depression program

Mar 3, 2026 07:00AM

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Jan 16, 2026 07:00AM

Jan 13, 2026 07:02AM

Jan 8, 2026 07:06AM

Jan 8, 2026 07:00AM AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference

Nov 14, 2025 06:52AM

Nov 12, 2025 07:00AM

Nov 10, 2025 07:00AM

Nov 10, 2025 07:00AM

Nov 5, 2025 07:00AM

Oct 22, 2025 06:23AM

Oct 16, 2025 04:11PM atai Life Sciences gets FDA breakthrough therapy status for depression drug

Oct 16, 2025 04:10PM

Sep 24, 2025 06:29AM

Sep 23, 2025 07:00AM

Sep 23, 2025 07:00AM

Aug 14, 2025 07:00AM

Jul 2, 2025 11:59AM

Jul 2, 2025 06:42AM atai Life Sciences N.V (ATAI) PT Raised to $12 at Canaccord Genuity

Jul 1, 2025 09:50AM

Jul 1, 2025 06:05AM

Jul 1, 2025 06:05AM

Jul 1, 2025 06:01AM

Jul 1, 2025 06:00AM

Nov 13, 2024 08:00AM

Jun 5, 2024 08:55AM Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment

Jun 5, 2024 07:48AM

327,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All